Bank of Qingdao (BQD, 03866) will hold its 2025 Annual Shareholders’ Meeting on 28 May 2026 in Qingdao, Shandong.
Key items on the agenda are as follows:
Financial Results (FY 2025) • Operating income rose 7.97% to RMB 14.57 billion. • Net profit increased 21.61% to RMB 5.36 billion; net profit attributable to shareholders reached RMB 5.19 billion, up 21.66%. • Total assets grew 18.12% to RMB 814.96 billion. • Asset quality improved: NPL ratio fell 0.17 ppt to 0.97%; provision coverage climbed to 292.30%. • Capital adequacy ratio stood at 13.37%, with a core tier-one ratio of 8.67%.
Dividend Proposal • Cash dividend of RMB 1.80 (tax-inclusive) per 10 shares, totalling about RMB 1.05 billion, equating to a 21.15% payout of consolidated attributable profit. • Record date for H shareholders: 7 June 2026; payment date: 24 June 2026. Dividends to H shareholders will be paid in Hong Kong dollars using the average RMB/HKD central parity rate for the five business days preceding the AGM.
Capital Allocation • Statutory surplus reserve: RMB 497 million. • General reserve: RMB 1.63 billion. • Perpetual bond interest: RMB 233 million.
Auditors and Fees • Re-appointment of Ernst & Young Hua Ming LLP (PRC) and Ernst & Young (international) for 2026; combined audit and internal-control fees set at RMB 4.05 million, unchanged from the previous year.
Board Composition • Nomination of Mr Zhang Shixing as independent director, pending regulatory approval.
Related-Party Transactions • Ordinary related transactions for 2026 estimated at RMB 234.64 billion (credit), RMB 314.43 billion (deposits) and RMB 133.08 billion (other non-credit).
Other Resolutions • Three-year (2026-2028) capital plan, including maintenance of core tier-one ratio above 7.7% and overall CAR above 11%. • Annual designated donation of 0.25% of prior-year pre-tax profit to Bank of Qingdao Charity Foundation (≈RMB 14.14 million for 2026). • Board authorised to decide on 2026 interim dividend. • Adoption of interim total salary measures and new remuneration framework for directors and senior management; 2026 remuneration plan and 2024 settlement tabled for approval. • General mandate sought to issue new A and/or H shares (including preference shares or convertible bonds) of up to 20% of existing issued ordinary share capital.
Voting Arrangements • Shareholders registered by 21 May 2026 may attend and vote. Proxy forms must be lodged 24 hours before the meeting.
No other matters requiring shareholder action were reported. The Board recommends voting in favour of all proposals.